title: Is graft versus leukaemia separable from graft versus host disease?
authors.affiliation: Dept. of Haematology, Royal Postgraduate Medical School, London, U.K.
authors.forename: Y Z
authors.initials: YZ
authors.lastname: Jiang
authors.forename: D
authors.initials: D
authors.lastname: Macdonald
authors.forename: J O
authors.initials: JO
authors.lastname: Cullis
authors.forename: A J
authors.initials: AJ
authors.lastname: Barrett
mesh_terms: D015703:Antigens, CD / Q000276:immunology; D000951:Antigens, Neoplasm / Q000276:immunology; D002478:Cells, Cultured; D002999:Clone Cells / Q000276:immunology / Q000473:pathology; D006087:Graft vs Host Reaction; D006680:HLA Antigens / Q000276:immunology; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000276:immunology / Q000473:pathology*; D008212:Lymphocyte Depletion; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D014407:Tumor Cells, Cultured / Q000473:pathology
chemical_list: D015703:Antigens, CD; D000951:Antigens, Neoplasm; D006680:HLA Antigens